公募基金方面，本期较上一期持股增加的公募基金共计16个，主要包括东吴移动互联混合A、景顺长城 品质长青混合A、东吴嘉禾优势精选混合A、东吴新趋势价值线混合、兴业研究精选混合A等，持股增 加占比达0.66%。本期较上一季度持股减少的公募基金共计63个，主要包括睿远成长价值混合A、富国 长期成长混合A、景顺长城研究精选股票A、南方中证500ETF、兴全合兴混合A等，持股减少占比达 4.72%。本期较上一季度新披露的公募基金共计711个，主要包括景顺长城景气进取混合A、富国天惠成 长混合(LOF)A/B、大摩数字经济混合A、圆信永丰兴诺、兴业兴睿两年持有期混合A等。本期较上一季 未再披露的公募基金共计40个，主要包括兴全合润混合A、兴全合宜混合A、汇添富中盘积极成长混合 A、兴全全球视野股票、建信中小盘先锋股票A等。 2025年4月10日，水晶光电(002273.SZ)发布2024年年度报告。截至2025年4月09日，共有802个机构投资 者披露持有水晶光电A股股份，合计持股量达6.50亿股，占水晶光电总股本的46.76%。其中，前十大机 构投资者包括星星集团有限公司、香港中央结算有限公司、杭州深改哲新企业管理合伙 ...

将投中网设为"星标⭐"，第一时间收获最新推送 速览投资风口，掌握资本律动。 作者丨 长风 来源丨 东四十条资本 大家好，我是长风。今天给大家带来上周资本市场的专业投研信息。 上周焦点回顾： 新消费赛道，旅游住宿受重视。 3月31日消息，汇智国际旅游正式宣布完成新一轮亿元B+轮融资。本轮融资由沣源资本领投、华山资本跟投，老股东 明裕创投持续加码。同一天，国内智能民宿运营商杭州团家商业运营管理有限公司宣布完成3000万元A轮融资。本轮融资由早行人创业投资（海南）有 限公司独家领投。 硬科技赛道，具身智能亿元融资不断。 上周，具身智能企业千寻智能Spirit AI宣布完成 5.28 亿元人民币 Pre-A 轮融资。本轮融资由阿美风险投资旗 下 Prosperity7 Ventures(P7) 领投，招商局创投、广发信德、靖亚资本、东方富海、华控基金等多家资本深度参与，华发集团、浙江省科创母基金与 上市公司浙江东方在杭州共同发起设立的善富科创子基金战略加持。此外，专注于打造"一脑多形"具身智能机器人的人工智能公司星海图接连完成A2、 A3轮系列融资，总融资额超3亿元人民币，本系列融资由凯辉基金领投，联想创投、海尔资本 ...

Core Viewpoint - The eye health awareness among the Chinese population is increasing, leading to significant growth in the ophthalmic optical instrument industry, which is expected to reach a market size of approximately 4 billion yuan by 2024 [1][15]. Industry Overview - Ophthalmic optical instruments are essential for diagnosing and treating eye diseases, including devices like computer visual field analyzers, automatic refractors, corneal topographers, and fundus cameras [3][4]. - The industry has seen remarkable advancements in technology and product development, with domestic companies enhancing their R&D capabilities and launching high-quality products [1][15]. Market Growth - The market size of China's ophthalmic optical instrument industry has been continuously growing from 2017 to 2023, with projections indicating it will reach around 4 billion yuan in 2024 [1][15]. - The increasing prevalence of age-related eye diseases and lifestyle changes, such as prolonged use of electronic devices, are driving the demand for ophthalmic medical services [13][25]. Industry Chain - The upstream of the ophthalmic optical instrument industry includes suppliers of optical glass and plastic, which are crucial for manufacturing high-quality instruments [9][11]. - The midstream consists of various manufacturers of ophthalmic optical instruments, while the downstream includes hospitals, clinics, and optical shops where these instruments are utilized [9]. Competitive Landscape - The market concentration in the ophthalmic optical instrument industry is relatively high, with a few companies dominating specific product areas like fundus cameras and OCT devices [17][18]. - Key players in the industry include companies like 图拜医疗, 康捷医疗, and 新眼光, which are focusing on high-end product development [17][18]. Policy Environment - Recent policies have been introduced to promote the standardization and regulation of the medical device industry, providing favorable conditions for the growth of the ophthalmic optical instrument sector [4][6]. - The government aims to enhance the quality and safety of medical devices, ensuring a robust regulatory framework by 2035 [6]. Future Trends - The market is expected to further penetrate various healthcare institutions, with handheld devices likely to see widespread adoption in grassroots medical facilities [23]. - The integration of artificial intelligence and big data into ophthalmic optical instruments is becoming mainstream, leading to the development of smart devices that enhance diagnostic capabilities [24][25].

点击招商研究小程序查看PDF报告原文 事件 ： 公司发布 2024 年报， 24 全年营收 382.94 亿元，同比 +20.9% ；净利润 26.99 亿元，同比 +145.5% 。 我们点评如下 ： 2 4H2 净利润延续同比高增， 24 全年毛利率及净利润显著提升，总体表现符合预期。 公司 24 全年营 收 382.9 亿元，同比 +20.9% ，增长主要受益于智能手机市场复苏带动手机镜头及模组收入增加，同时 汽车智能化快速发展带动车载镜头及模组收入增长，以及 XR 相关业务收入的上升。分产品看， 2024 年公司光电产品 / 光学零件 / 光学仪器营收分别为 262/117/4 亿元，同比 +21%/+23%/-18% 。 24 全年公 司毛利率 18.3% ，同比 +3.8pct ；净利润 27.0 亿元，同比 +145.5% ；盈利能力提升主要受益于手机镜 头和摄像模组的产品结构改善。 24H2 公司总体营收 193.1 亿元，同比 +10.4% ，净利润 16.2 亿元，同 比 +145.5% 。 手机：目标 25 年手机镜头及手机摄像模组出货量、毛利率均将提升。 2024 年公司手机产品营收 ...

增强控制力 公开资料显示，欧菲微电子是欧菲光旗下指纹识别整体方案提供商，主要产品有指纹芯片封装、模组以及相关测试软件等，除应用于 手机领域外，还开拓金融支付、安防、汽车、健康等领域生物识别应用。 星标 ★ IPO日报 精彩文章第一时间推送 又一家上市公司筹划重大资产重组。 3月31日晚间，欧菲光集团股份有限公司(下称"欧菲光"，002456.SZ)发布公告称，公司正在筹划以发行股份及支付现金的方式购买公司 控股子公司欧菲微电子（南昌）有限公司（简称"欧菲微电子"）的少数股权及江西晶浩光学有限公司（简称"江西晶浩"）的少数股权 资产，同时公司拟发行股份募集配套资金。 欧菲光表示，因标的公司估值及定价尚未最终确定，本次交易预计可能构成重大资产重组。本次交易不会导致公司实际控制人发生变 更，不构成重组上市。 制图：佘诗婕 天眼查显示，目前，欧菲微电子由欧菲光持股71.6345%、南昌市产盟投资管理有限公司持股28.2461%、深圳欧菲创新科技有限公司持 股0.1194%。 2023年以及2024年上半年，欧菲微电子实现营业收入54.9亿元、22.16亿元，净利润2.38亿元、6998.14万元。 而江西晶浩涉及的经 ...

证券代码：688502 证券简称：茂莱光学 公告编号：2025-023 南京茂莱光学科技股份有限公司 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 ? 投资标的名称：茂莱光学标准品公司（暂定名，最终以市场监督管理部 门核准的名称为准，以下简称"深圳子公司"） ? 投资金额：1,500 万元 ? 相关风险提示： 素带来的风险。 一、对外投资概述 （一）对外投资的基本情况 南京茂莱光学科技股份有限公司（以下简称"公司"或"茂莱光学"）深耕 精密光学行业二十余载，拥有技术积累和资源优势，具备快速响应客户需求、提 供相应的解决方案的能力，但在大众市场知名度有待提高，品牌传播渠道相对单 一。为进一步提升品牌知名度和市场占有率，公司拟投资 1,500 万元在深圳设立 全资子公司"茂莱光学标准品公司"（MLVision）。深圳子公司成立后将以技术 创新和可持续发展为核心，依托茂莱光学的技术积累和资源优势，打造全球领先 的光学标准品品牌；通过高效运营和优质服务，为客户提供高精度、高质量的光 学标准品解决方案，有效应对日益激烈的市场竞争和 ...

Core Viewpoint - The Shenzhen Stock Exchange issued a regulatory letter to Zhongshan United Optoelectronics Technology Co., Ltd. for inaccurate and untimely information disclosure regarding its "heavy-duty quadruped robot" business, raising concerns about the company's governance and financial health [2] Financial Performance - In the first half of 2024, the company's revenue reached 848 million yuan, a year-on-year increase of 5.75%, but net profit declined by 27.67% to 28.25 million yuan, with a non-recurring net profit drop of 33.32% [3] - The decline in profitability is attributed to a significant increase in R&D expenses, which rose by 34.28% to 104 million yuan, and intensified competition in the consumer electronics market affecting gross margins [3] - The company's operating cash flow turned negative, with a net outflow of 53.81 million yuan, a decrease of 61 million yuan year-on-year, and free cash flow worsened to -37.30 million yuan, indicating increased pressure on the cash flow [3] Financial Health - As of the end of Q3 2024, the company's debt-to-asset ratio rose to 42.43%, an increase of 6.67 percentage points compared to the same period in 2023, with long-term borrowings increasing by 48.84% [4] - Interest-bearing debt ratio increased to 17.64%, while inventory value reached 441 million yuan, accounting for 27.23% of net assets, a 20.29% increase from the end of the previous year [4] - If market demand does not meet expectations, liquidity risks may further escalate [4] Business Performance - The company maintains strong competitiveness in traditional sectors such as security monitoring and intelligent driving, with high-end lens products dominating the security market and improving production capacity in vehicle-mounted lenses [5] - However, the failure of the robot project highlights deficiencies in the company's technological reserves and commercialization capabilities in emerging fields, with high R&D investments not translating into actual revenue [5] Future Outlook - The Shenzhen Stock Exchange has mandated the company’s board to immediately rectify and enhance compliance in information disclosure [5] - The company plans to release its 2024 annual report on April 21, 2025, with market focus on debt structure optimization, cash flow improvement, and adjustments in emerging businesses [5] - In the short term, the company needs to restore investor confidence, while long-term sustainability will depend on balancing innovation investments with profitability in its optical core business [5]

Investment Rating - The report does not explicitly provide an investment rating for the companies discussed [3]. Core Insights - The new stock market activity has decreased, with the first-day gains and opening valuations of mainboard new stocks rising in March 2025 [1][12]. - In March, the first-day gains and opening valuations of new stocks on the ChiNext board decreased, while those on the mainboard increased [2][25]. - The report highlights specific new stocks that have recently been listed, including Hongjing Optoelectronics and Hengxin Life, which experienced significant fluctuations in their stock prices [1][25]. Summary by Sections New Stock Market Activity - In March 2025, the mainboard saw an increase in the first-day gains and opening valuations, while the overall activity in the new stock market declined, with only 12 out of 46 new stocks (26.09%) recording positive gains [1][12]. - The ChiNext board had new listings including Hongjing Optoelectronics and Hengxin Life, with first-day gains of 210.26% and 119.44% respectively, but later recorded declines exceeding 10% [25][26]. - The report notes that the total number of new stocks listed in 2023 has reached 333, raising a total of 407.88 billion yuan [12]. Key New Stocks - The report identifies key new stocks that have been listed since January 2023, including Hongjing Optoelectronics, Sikan Technology, and others, highlighting their core products and market performance [49][51]. - Specific attention is given to Sikan Technology, which focuses on 3D visual digital products and has shown promising financial forecasts [44][45]. Market Valuation Trends - The report indicates that the first-day price-to-earnings (P/E) ratios for new stocks on the ChiNext board have increased to 19.24 times in March, compared to 17.14 times in February, while the mainboard's P/E ratio decreased to 15.56 times [17][29]. - The opening valuations for new stocks on the mainboard have also shown an upward trend, with a notable increase in the first-day gains compared to previous months [29][33].

A股市场上午低位震荡，主要指数总体表现低迷。 今天A股市场有一只新股上市，为胜科纳米，该股上午盘中涨幅一度超过240%。 上午A股市场最大亮点之一来自于新股方面。 国家卫生健康委办公厅发布关于组织开展2025年人口高质量发展研究揭榜攻关活动的通知。 其中，完善生育支持政策体系方面，通知提出，基于多源数据和国内外比较的视角，分析当前我国生育医疗服务、生育假期、生育保险、育儿补贴、托育服务、教 育、住房、就业等支持措施实施现状及存在问题，开展政策效果评估，研究提出进一步完善生育支持措施、加强中长期政策储备的建议。 贝因美直线拉升触及涨停，骑士乳业、孩子王、爱婴室、西部牧业、金发拉比等快速跟涨。 港股市场方面，科技股整体重挫，恒生科技指数盘中一度跌逾3%。 恒生科技指数成份股中，比亚迪电子盘中跌幅超过9%。舜宇光学科技重挫，盘中跌幅一度超过8%。 A股整体低位震荡 新股盘中暴涨超过240% A股市场上午低位震荡，主要指数总体表现低迷。 行业板块和赛道方面，煤炭、电力、运输服务、交通设施、供气供热等板块涨幅居前，公共交通、船舶等板块领跌。 概念板块方面，超导概念、核电概念等板块涨幅居前，水产品、算力租赁等板块跌幅居前 ...

当下智能技术的日新月异驱动着各类数字终端产品的快速发展，国产替代大浪潮的冲刷下，国内光学镜 头厂商迎来新机遇。 近日，以领跑全球光电细分领域为目标的弘景光电(301479)正式完成了IPO，迎来了企业发展的新阶 段。"公司将抓住全球产业结构调整的机遇，专注光学核心器件的研发设计与制造，推动公司向更高的 战略目标迈进。"弘景光电董事长、总经理赵治平表示。 新兴产业带来新机遇 在新兴消费的全景/运动相机领域，来自中国的影石创新是在全球范围内的领先企业，2022年市场占有 率高达50.7%。作为影石创新的核心供应商，弘景光电为其研发设计领先于行业的4800万像素全景相机 光学镜头及摄像模组，进而确立了在全球全景相机镜头模组市场的占有率达到25%以上的优势地位。 此外，在智能汽车领域，公司2022年在全球车载光学镜头市场占有率3.70%，排名全球第六；在智能家 居领域，公司2023年在全球家用摄像机（含可视门铃）光学镜头领域的市场占有率为9.95%。 "戴姆勒-奔驰、日产、本田、奇瑞、比亚迪、吉利、长城、埃安、蔚来、小鹏、飞凡等众多车厂和 Tier1，均将弘景光电作为定点企业。目前，公司产品已经在国际光学镜头市场拥有 ...